MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by targeting CX3CL1

被引:2
|
作者
Wang, F-R [1 ]
Xu, S-H [1 ]
Wang, B-M [1 ]
Wang, F. [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Trauma Emergency Surg, Jinan, Shandong, Peoples R China
关键词
miR-485-5p; Osteosarcoma (OA); CX3CL1; CELL-PROLIFERATION; EXPRESSION; INVASION; MIGRATION; MIRNA; PROGRESSION; MECHANISMS; SURVIVAL;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To investigate the potential effect of miR-485-5p on the development of osteosarcoma (OA) and its relevant mechanism. PATIENTS AND METHODS: The expression level of miR-485-5p was detected in OA tissues and cells (MG-63) comparing with corresponding adjacent normal tissues and normal human osteoblastic cell lines (Hfob1.19). respectively. Luciferase assay was performed to evaluate the interaction between miR-485-5p and CX3CL1, the effects of miR-485-5p on MG-63 cells were determined by subsequent experiments including cell proliferation, expression level of CX3CL1, detection of invasion and migration capacities. RESULTS: In our present research, miR-485-5p was down-regulated in OA tissues and we got the same result in OA cells. In order to obtain potential target of miR-485-5p, we checked it in three publicly available algorithms, Target-Scan, miRDB and microRNA. We found that CX3CL1 is a direct target of miR-485-5p, and Luciferase assays confirmed our hypothesis. The results showed that decreased expression of CX3CL1 resulting from the up-regulation of miR-485-5p could decelerate cell proliferation, invasion and migration in OA cells. CONCLUSIONS: We showed the suppressor function of miR-485-5p in OA by targeting CX3CL1, indicating that miR-485-5p/CX3CL1 axis might be a potential therapeutic target for the treatment of OA.
引用
收藏
页码:7197 / 7204
页数:8
相关论文
共 50 条
  • [1] miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2
    Chen, Zhijun
    Li, Qingwen
    Wang, Sheng
    Zhang, Jiajun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (04) : 1136 - 1142
  • [2] MiR-150-5p inhibits cell proliferation and metastasis by targeting FTO in osteosarcoma
    Xu, Lichen
    Zhang, Pan
    Zhang, Guiqi
    Shen, Zhaoliang
    Bai, Xizhuang
    ONCOLOGY RESEARCH, 2024, 32 (11) : 1777 - 1789
  • [3] miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN
    He, Ming
    Shen, Peng
    Qiu, Chuang
    Wang, Jiashi
    AGING-US, 2019, 11 (15): : 5744 - 5756
  • [4] MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression
    C Lou
    M Xiao
    S Cheng
    X Lu
    S Jia
    Y Ren
    Z Li
    Cell Death & Disease, 2016, 7 : e2159 - e2159
  • [5] MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression
    Lou, C.
    Xiao, M.
    Cheng, S.
    Lu, X.
    Jia, S.
    Ren, Y.
    Li, Z.
    CELL DEATH & DISEASE, 2016, 7 : e2159 - e2159
  • [6] miR-485-5p promotes osteoporosis via targeting Osterix
    Zhang, S-Y
    Gao, F.
    Peng, C-G
    Zheng, C-J
    Wu, M-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (15) : 4792 - 4799
  • [7] Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN
    Sun, Xiangjun
    Liu, Yonglei
    Li, Ming
    Wang, Mingchun
    Wang, Yutong
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 72 : 58 - 65
  • [8] miR-485-5p suppresses Schwann cell proliferation and myelination by targeting cdc42 and Rac1
    Zhang, Zhan
    Li, Xuyang
    Li, Aipeng
    Wu, Guangzhi
    EXPERIMENTAL CELL RESEARCH, 2020, 388 (01)
  • [9] miR-485-5p alleviates Alzheimer's disease progression by targeting PACS1
    He, Chuan
    Su, Caixia
    Zhang, Wentong
    Wan, Qi
    TRANSLATIONAL NEUROSCIENCE, 2021, 12 (01) : 335 - 345
  • [10] miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin
    Wang, Meng
    Cai, Wen-Run
    Meng, Ran
    Chi, Jiang-Rui
    Li, Yun-Rui
    Chen, Ao-Xiang
    Yu, Yue
    Cao, Xu-Chen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 501 (01) : 48 - 54